| Update on SARS-CoV-2 omicron variant of concern and its peculiar mutational profile M Alkhatib, R Salpini, L Carioti, FA Ambrosio, S D’Anna, L Duca, G Costa, ... Microbiology spectrum 10 (2), e02732-21, 2022 | 57 | 2022 |
| Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure R Salpini, S D’Anna, L Benedetti, L Piermatteo, U Gill, V Svicher, ... Frontiers in microbiology 13, 972687, 2022 | 23 | 2022 |
| Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and … L Piermatteo, S D’Anna, A Bertoli, M Bellocchi, L Carioti, L Fabeni, ... Emerging Microbes & Infections 12 (1), 2219347, 2023 | 10 | 2023 |
| Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis R Salpini, S D'Anna, L Piermatteo, V Svicher Journal of Viral Hepatitis 29 (12), 1038-1047, 2022 | 9 | 2022 |
| SARS-CoV-2 mutations and variants may muddle the sensitivity of COVID-19 diagnostic assays M Alkhatib, L Carioti, S D’Anna, F Ceccherini-Silberstein, V Svicher, ... Microorganisms 10 (8), 1559, 2022 | 9 | 2022 |
| Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort A Cervo, A Russo, D Di Carlo, A De Vito, L Fabeni, S D'Anna, L Duca, ... Journal of Global Antimicrobial Resistance 34, 141-144, 2023 | 6 | 2023 |
| Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral … R Salpini, L Piermatteo, G Torre, S D'Anna, S Khan, L Duca, A Bertoli, ... International Journal of Infectious Diseases 138, 1-9, 2024 | 4 | 2024 |
| HBeAg levels vary across the different stages of HBV infection according to the extent of immunological pressure and are associated with therapeutic outcome in the setting of … L Piermatteo, M Alkhatib, S D’Anna, V Malagnino, A Bertoli, E Andreassi, ... Biomedicines 9 (10), 1352, 2021 | 4 | 2021 |
| HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses B Sun, KAS da Costa, A Alrubayyi, J Kokici, N Fisher-Pearson, N Hussain, ... Hepatology 80 (3), 649-663, 2024 | 3 | 2024 |
| Frequency of Atypical Mutations in the Spike Glycoprotein in SARS-CoV-2 Circulating from July 2020 to July 2022 in Central Italy: A Refined Analysis by Next Generation Sequencing MC Bellocchi, R Scutari, L Carioti, M Iannetta, G Marchegiani, ... Viruses 15 (8), 1711, 2023 | 3 | 2023 |
| HBcrAg tightly correlates with elevated HDV replicative activity and with enhanced liver inflammation and damage: role of HBcrAg as a biomarker of liver disease progression in … R Salpini, L Piermatteo, U Gill, A Battisti, M Alkathib, S D'Anna, R Scutari, ... REVIEWS IN ANTIVIRAL EDUCATION 3, 2022 | 3 | 2022 |
| Can a different formulation of Vitamin D3 allow savings? An analysis from an italian regional perspective M Sano, P Dutto, S D’Anna, C Rognoni Health Services Research and Managerial Epidemiology 6, 2333392819861881, 2019 | 3 | 2019 |
| Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort AA Monforte, A Tavelli, R Salpini, L Piermatteo, S D'Anna, S Carrara, ... Liver International 44 (2), 603-613, 2024 | 2 | 2024 |
| In the setting of HIV-infection, HBV-reactivation is revealed by highly sensitive assays in a conspicuous fraction of anti-HBc-positive/HBsAg-negative patients switching to … R Salpini, S D’Anna, M Alkhatib, L Piermatteo, A Tavelli, E Quiros-Roldan, ... Journal of Hepatology, 284-285, 2022 | 2 | 2022 |
| The composition of HBsAg along with HDV-RNA predicts virological response in chronic hepatitis delta patients treated with bulevirtide for 48 weeks S D’Anna, R Salpini, E Degasperi, L Duca, L Piermatteo, I Grossi, ... Journal of Hepatology 80, S798-S798, 2024 | 1 | 2024 |
| Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort A d’Arminio Monforte, A Tavelli, R Salpini, L Piermatteo, S D'Anna, ... Liver International 44 (2), 603-613, 2024 | 1 | 2024 |
| Ultrasensitive HBV-RNA quantification by droplet digital PCR is a promising biomarker to optimize the staging of chronic HBV infection and to identify minimal viral activity … R Salpini, L Piermatteo, S D’Anna, L Duca, G Torre, A Guerra, C Boarini, ... J Hepatol 78, S1105, 2023 | 1 | 2023 |
| New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis V Svicher, R Salpini, S D’Anna, L Piermatteo, M Iannetta, V Malagnino, ... Frontiers in Oncology 13, 1143258, 2023 | 1 | 2023 |
| Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy R Salpini, S D'Anna, M Alkhatib, L Piermatteo, A Tavelli, L Benedetti, ... International Journal of Infectious Diseases 150, 107294, 2025 | | 2025 |
| HBS ISOFORMS AS INNOVATIVE BIOMARKERS IN PREDICTING VIROLOGICAL RESPONSE TO BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS DELTA S D'Anna, R Salpini, E Degasperi, L Duca, MP Anolli, L Piermatteo, ... HEPATOLOGY 80, S668-S669, 2024 | | 2024 |
